Prednisone (Deltasone, Orasone, Liquid Pred)

Category:

  • Miscellaneous

Description:

  • Corticosteroid (systemic)

Indications:

  • Anti-inflammatory or immunosuppressant agent in the treatment of a variety of diseases including those of hematologic, allergic, inflammatory, neoplastic, and autoimmune origin

Contraindications:

  • Systemic fungal infections

Precautions:

  • Pregnancy category B; compatible with breast feeding

  • Psychosis, acute glomerulonephritis, amebiasis, cerebral malaria, child < 2 years

  • Elderly, AIDS, tuberculosis, diabetes mellitus, glaucoma, osteoporosis

  • Ulcerative colitis, CHF, myasthenia gravis, renal disease, esophagitis

  • Peptic ulcer, ocular herpes simplex, live virus vaccines, hypertension

Adverse Reactions (Side Effects):

  • CNS: depression, headache, mood changes, psychosis, seizures, vertigo

  • CV: CHF, hypertension, tachycardia, thromboembolism, thrombophlebitis

  • EENT: blurred vision, cataracts, increased intraocular pressure

  • GI: abdominal distension, diarrhea, GI hemorrhage (esophagitis, peptic ulcer) increased appetite, nausea, pancreatitis

  • HEME: leukocytosis

  • METAB: Cushingoid syndrome, decreased glucose tolerance, decreased testosterone levels, growth suppression in children, HPA axis suppression, hypocalcemia, hypokalemia, metabolic alkalosis, sodium and fluid retention

  • MS: aseptic necrosis of femoral and humeral heads, fractures, muscle mass loss, osteoporosis, weakness

  • SKIN: acne, bruising, ecchymosis, petechiae, poor wound healing, striae, suppression of skin test reactions, thin fragile skin

Dosage:

Administered orally (tablet, solution)

  • Adult:   PO 50-60mg daily divided 1-4 times daily

    • Physiologic replacement: PO 4-5mg per square meter daily

    • Hepatic disease: Conversion to active metabolite, prednisolone, may be impaired; use prednisolone at same dosage

  • Child:   

    • Anti-inflammatory/immunosuppressive: PO 0.05-2 mg/kg/day divided 1-4 times

    • Acute asthma: PO I-2 mg/kg/day divided 1-2 times daily for 3-5 days

    • Asthma, long-term therapy: PO <1 year 10mg every other day, 1-4 years 20mg every other day, 5-13 years 30mg every other day, >13 years 40mg every other day

Drug interactions:

  • NSAIDs: increased risk of GI ulceration

  • Antidiabetics: increased blood glucose in patients with diabetes

  • Salicylates: enhanced elimination of salicylates; possible subtherapeutic salicylate concentrations

  • Cyclosporine: possible increased concentrations of both drugs, seizures

 

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

Approved for public release; Distribution is unlimited.

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.

Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates, LLC.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

© 2015, Brookside Associates, LLC. All rights reserved

Other Brookside Products

 

 

Advertise on this site